As monkeypox spreads, a CEO fields calls for his vaccine; Illumina accused of ‘brazen’ attempt to quash competition

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: As monkeypox spreads, Bavarian Nordic's CEO is fielding calls for his vaccine, but doesn't see panic By Ed Silverman CDC Bavarian Nordic has suddenly become very popular as monkeypox threatens to become the latest global health concern. Read More STAT+: Guardant accuses Illumina of 'brazen' attempt to quash competition in ongoing legal battle By Jonathan Wosen Adobe Guardant attorneys called the suit a "brazen attempt by Illumina to put its chief rival out of business and stifle competition." Read More STAT+: Proton cancer centers continue to proliferate, despite shaky benefits and checkered financiers By Tara Bannow and Bob Herman Adobe Even as some proton therapy centers falter, some big-name hospitals are setting up the facilities to attract cancer patients. Read More Sponsor content by STAT+ Sign up for our free pop-up newsletter: ADA in 30 seconds Get insightful analysis of the data presented at the conference of the American Diabetes Association with this newsletter. STAT will be on top of all the news out of the event and will recap the most important advances in research and care for you from June 4-6. Sign up now. Opinion: STAT+: QR codes can help pharmaceutical companies in two big ways By Emily Johnson and Jenna Phillips Adobe QR codes can help biopharma companies reduce their environmental impact and create positive patient experiences. Read More STAT+: There may be a backdoor way for hospitals to get paid for uninsured Covid-19 care By Rachel Cohrs Eraldo Peres/AP The federal government shut down a program that paid for tests, treatments, and vaccines for the uninsured, but there may be a workaround. Read More STAT+: Flagship's latest startup launches with bold claim: the discovery of thousands of new human proteins By Ryan Cross — The Boston Globe Lane Turner/The Boston Globe ProFound Therapeutics said that it had identified tens of thousands of previously unknown proteins in the human body. Read More Thursday, May 26, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser